Losigamone
Chemical compound / From Wikipedia, the free encyclopedia
Losigamone (INN) is an investigational drug for the treatment of epilepsy. It has been studied as an add-on treatment for partial seizures.[1] Phase III clinical trials were conducted around the year 2000.[2]
Quick Facts Clinical data, ATC code ...
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
Chemical and physical data | |
Formula | C12H11ClO4 |
Molar mass | 254.67 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Close